Rayner Newsroom

Find out more about the latest news taking place at Rayner!



Rayner ESCRS Highlights - What Surgeons Are Saying About Their Experience With Rayner IOLs


Read More»
03/11/2015

The 2015 meeting of the European Society of Cataract and Refractive Surgeons (ESCRS) held in Barcelona, Spain, featured a number of presentations describing surgeons’ experience with Rayner’s portfolio of lenses including the Sulcoflex®, C-flex®, M-flex® and T-flex®.


Video: Refractive Surprises – Are They Really Taboo?


Read More»
27/10/2015

Professor Rudy Nuijts (The Netherlands) and Professor James Wolffsohn (United Kingdom) – speakers on the panel at Rayner’s 2015 ESCRS Educational Symposium ‘Refractive Surprise; the Big Taboo’ – as well as Drs Mark Cherny (Australia) and David Frazer (United Kingdom), who attended the event, share their views on the topic of refractive surprise in cataract surgery.


Video: Rayner’s Recently Acquired Ophteis OVD Range and What This Means for Cataract Surgery


Read More»
09/10/2015

Professor Steve Arshinoff discusses the importance of viscoelastic in cataract surgery at Rayner's Ophteis Acquisition event at the 2015 ESCRS in Barcelona.

Also included in the video, Rayner CEO Tim Clover and Professor Steve Arshinoff welcome guests and briefly introduce Ophteis to the Rayner family before commencing the cutting of a celebratory cake.


Rayner ASCRS Highlights: What Surgeons Are Saying About Rayner on the Podium


Read More»
23/06/2015

The 2015 meeting of the American Society of Cataract and Refractive Surgery (ASCRS) held in San Diego, CA, featured a number of presentations describing surgeons’ experience with Rayner’s portfolio of lenses including the C-flex, T-flex Aspheric Toric and Sulcoflex.

The Rayner Sulcoflex Pseudophakic Supplementary IOL


Excellent Functional Results for the Rayner C-flex® and Superflex® Aspheric, Aberration-Neutral Monofocal IOL


Read More»
04/06/2015

Rayner’s C-flex® and Superflex® aspheric and aberration-neutral monofocal intraocular lenses (IOLs) have been proved to “provide good and predictable functional results”, as the authors of a prospective clinical trial conclude in a recently published paper. 

The trial, conducted by Khoramnia R et al. from the International Vision Correction Research Centre (IVCRC) at the University of Heidelberg, Germany...


Patient Reported Outcomes Indicate that the Rayner C-flex® Monofocal IOL is Associated with Low Levels of Dysphotopsia and High Satisfaction


Read More»
16/04/2015

Rayner’s C-flex® intraocular lens (IOL) is associated with a low incidence of dysphotopsia and a high degree of patient satisfaction with postoperative visual outcomes, according to the findings from a study by Ashokkumar Vyas, FRCS (Ophth), recently published in Clinical & Experimental Ophthalmology.

 

Whilst a previous study by Tester et al (2000) reported unwanted imagery in patients implanted with following lenses (materials): 


Sulcoflex® Toric IOL: Excellent Long-Term Visual Outcomes Reported in Managing Pseudophakic Residual Astigmatism


Read More»
23/03/2015

A recent clinical study using Rayner's Sulcoflex® Toric IOL in patients with astigmatism following cataract surgery showed that this supplementary IOL provided predictable, stable and excellent optical and visual outcomes.

The paper by Drs Ferreira and Pinheiro...


‘Maximising Treatment Outcomes with Premium IOL Technology’ Highlights and Valuable Insights from Gerd U Auffarth and Peers.


Read More»
09/02/2015

Professor Gerd Auffarth, Professor Oliver Findl, Professor Michael Amon and Dr Victor Antunes were the panel of speakers at the Rayner satellite meeting presented at the XXXII Congress of the ESCRS in London.
Today, Rayner is pleased to announce that the key material from this well-attended symposium is now available in a print supplement.


Rayner Launches T-flex Aspheric Toric and Sulcoflex Toric System Packs in Korea


Read More»
05/02/2015

Rayner proudly announced today that the registration of both the Sulcoflex Toric IOL and T-flex Aspheric Toric IOL system packs has been approved by the Korean Food and Drugs Administration (KFDA) and are now available for sale in the Republic of Korea.

Approval details